NCT05299086View on ClinicalTrials.gov

As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis

NARecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

April 4, 2022

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Perennial Allergic RhinitisChild, Only
Interventions
DRUG

Intranasal Drug (INCS = Fluticasone furoate nasal spray, Placebo = Normal saline nasal spray)

The investigators want to compare the efficacy of intranasal corticosteroid between daily versus as needed use in children with perennial allergic rhinitis which had not been studied before.

Trial Locations (1)

10700

RECRUITING

Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER